Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Microscale cell culture platforms better mimic the in vivo cellular microenvironment than conventional, macroscale systems. Microscale cultures therefore elicit a more authentic response from cultured cells, enabling physiologically realistic in vitro tissue models to be constructed. The fabrication of interconnecting microchambers and microchannels allows drug absorption, distribution, metabolism and elimination to be simulated, and enables precise manipulation of fluid flow to replicate blood circulation. Complex, multi‐organ interactions can be investigated using “organ‐on‐a‐chip” toxicology screens. By reproducing the dynamics of multi‐organ interaction, the dynamics of various diseases and drug activities can be studied in mechanistic detail. In this review, we summarize the current status of technologies related to pharmacokinetic‐based drug toxicity testing, and the use of microtechnology for reproducing the interaction between multiple organs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The origins and the future of microfluidics
Whitesides, G. M. (2006) · Nature · doi:10.1038/nature05058 · Cited by 9,687 · cited 2×
“Microfluidics, which deals with very small quantities of liquids (nanoliters to microliters) using channels with dimensions of micrometers, has been largely applied to chemical synthesis and analytical chemistry [6].”
BackgroundMethodReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 3×
“One prominent example from the Ingber group [18] describes a lung-on-a-chip platform able to respond to bacterial and inflammatory cytokines introduced into alveolar space and replicate drug-induced pulmonary edema [41].”
BackgroundAbbott, A. (2003) · Nature · doi:10.1038/424870a · Cited by 1,234 · cited 1×
“These interactions often exist in three-dimensional (3D) context [3]; (ii) The cellular microenvironment found in vivo is often heterogeneous.”
BackgroundMicroscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219 · cited 3×
“[35] developed a liver-on-a-chip, in which the microscale architecture of the human liver tissue was reproduced by co-culturing hepatocytes and fibroblasts in precisely defined areas.”
BackgroundPDMS absorption of small molecules and consequences in microfluidic applications
Toepke, M. W., & Beebe, D. J. (2006) · Lab on a Chip · doi:10.1039/b612140c · Cited by 1,190 · cited 5×
“J. 2013, 8 6 © 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Ithis work, liver slices were sandwiched between PDMS layers and perfused with media.”
BackgroundInfluentialA Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993 · cited 2×
“One prominent example from the Ingber group [18] describes a lung-on-a-chip platform able to respond to bacterial and inflammatory cytokines introduced into alveolar space and replicate drug-induced pulmonary edema [41].”
BackgroundEngineering of functional, perfusable 3D microvascular networks on a chip
Kim, S., Lee, H., Chung, M., & Jeon, N. L. (2013) · Lab on a Chip · doi:10.1039/c3lc41320a · Cited by 872 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundHuman kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849 · cited 1×
“During the last few years, several organ-on-a-chip systems have been developed, including blood vessel [32, 33], liver [34, 35], gastrointestinal tract [19, 36, 37], blood-brain-barrier [38, 39], lung [18, 40, 41], kidney [42, 43], and heart [21, 44, 45] equivalents.”
BackgroundMicroengineered hydrogels for tissue engineering
Khademhosseini, A., & Langer, R. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.021 · Cited by 830 · cited 1×
“Therefore, recent research efforts have been directed towards fabricating hydrogels into 3D shapes mimicking the geometry of the target organs [25].”
BackgroundDesign of pressure-driven microfluidic networks using electric circuit analogy
Oh, K. W., Lee, K., Ahn, B., & Furlani, E. P. (2012) · Lab Chip · doi:10.1039/c2lc20799k · Cited by 685 · cited 1×
“The analogy between electrical circuits and microfluidic devices not only applies to a single channel, but it can also be extended to a more complex network of microchannels [30].”
Background
Cited by
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
“Integrating multiple organ types into one chip, termed as body-on-a-chip, can be powerful for comprehending the pharmacokinetics and pharmacodynamics of drug molecules.(119,120) However, developing screeningcompatible body-on-a-chip remains a challenging task, in particular when one considers the known allometric scal…”
BackgroundA liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Lee, H., & Cho, D.-W. (2016) · Lab on a Chip · doi:10.1039/c6lc00450d · Cited by 363
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
3D printed nervous system on a chip
Johnson, B. N., Lancaster, K. Z., Hogue, I. B., Meng, F., Kong, Y. L., Enquist, L. W., & McAlpine, M. C. (2016) · Lab on a Chip · doi:10.1039/c5lc01270h · Cited by 191
Bone-on-a-chip: Microfluidic technologies and microphysiologic models of bone tissue
Mansoorifar, A., Gordon, R., Bergan, R. C., & Bertassoni, L. E. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202006796 · Cited by 142
Multi-Organs-on-Chips: Towards Long-Term Biomedical Investigations
Zhao, Y., Kankala, R. K., Wang, S.-B., & Chen, A.-Z. (2019) · Molecules · doi:10.3390/molecules24040675 · Cited by 134
“The inaccurate prediction of the PK-PD profile of any drug can increase the failure rate of its development process [53,54].”
BackgroundOrgan‐on‐a‐Chip Technology for Reproducing Multiorgan Physiology
Lee, S. H., & Sung, J. H. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700419 · Cited by 127
Self-citationBioprinting of 3D tissues/organs combined with microfluidics
Ma, J., Wang, Y., & Liu, J. (2018) · RSC Advances · doi:10.1039/c8ra03022g · Cited by 113
Zhou, L., Huang, J., Li, C., Gu, Q., Li, G., Li, Z. A., Xu, J., Zhou, J., & Tuan, R. S. (2025) · Med · doi:10.1016/j.medj.2025.100667 · Cited by 141
A 3D printed microfluidic perfusion device for multicellular spheroid cultures
Ong, L. J. Y., Islam, A., DasGupta, R., Iyer, N. G., Leo, H. L., & Toh, Y.-C. (2017) · Biofabrication · doi:10.1088/1758-5090/aa8858 · Cited by 112
Bioprinters for organs-on-chips
Miri, A. K., Mostafavi, E., Khorsandi, D., Hu, S.-K., Malpica, M., & Khademhosseini, A. (2019) · Biofabrication · doi:10.1088/1758-5090/ab2798 · Cited by 121
“The main element of such platforms is the micro-tissue model that includes biomimetic structured cellular components to represent a specific organ or tissue connected to perfused channels [3].”
BackgroundPeela, N., Truong, D., Saini, H., Chu, H., Mashaghi, S., Ham, S. L., Singh, S., Tavana, H., Mosadegh, B., & Nikkhah, M. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.04.017 · Cited by 91
“Typical pharmacokinetic studies describe drug distribution within the body by testing the specific drug concentration in the plasma and various tissues [302].”
BackgroundZheng, F., Xiao, Y., Liu, H., Fan, Y., & Dao, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000024 · Cited by 107
Recent progress in lab-on-a-chip for pharmaceutical analysis and pharmacological/toxicological test
Ai, Y., Zhang, F., Wang, C., Xie, R., & Liang, Q. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.06.026 · Cited by 91
Building three-dimensional lung models for studying pharmacokinetics of inhaled drugs
Barros, A. S., Costa, A., & Sarmento, B. F. C. C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.008 · Cited by 76
The crossing and integration between microfluidic technology and 3D printing for organ-on-chips
Mi, S., Du, Z., Xu, Y., & Sun, W. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01661e · Cited by 77
Digital Twins for Tissue Culture Techniques—Concepts, Expectations, and State of the Art
Möller, J., & Pörtner, R. (2021) · Processes · doi:10.3390/pr9030447 · Cited by 61
“Additionally, flow-induced dynamic effects and mechanical stimuli [33–35] and interactions between multiple organs [36] need to be considered.”
BackgroundCANDO and the infinite drug discovery frontier
Minie, M., Chopra, G., Sethi, G., Horst, J. A., White, G. W. N., Roy, A., Hatti, K. S., & Samudrala, R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.018 · Cited by 69
Hydrogel‐based three‐dimensional cell culture for organ‐on‐a‐chip applications
Lee, S. H., Shim, K. Y., Kim, B., & Sung, J. H. (2017) · Biotechnology Progress · doi:10.1002/btpr.2457 · Cited by 63
“allow for more accurate prediction and analysis of cellular responses in relation to the efficacy of drugs and therapeutic agents.(12) Various organ models have been developed based on these principles, including gut, liver, skin, and vasculature.”
BackgroundSelf-citationA microfluidic chip with gravity‐induced unidirectional flow for perfusion cell culture
Lee, D. W., Choi, N., & Sung, J. H. (2019) · Biotechnology Progress · doi:10.1002/btpr.2701 · Cited by 54
Self-citationPfannkuche, J., Guo, W., Cui, S., Ma, J., Lang, G. M., Peroglio, M., Richards, R. G., Alini, M., Grad, S., & Li, Z. (2019) · Connective Tissue Research · doi:10.1080/03008207.2019.1665652 · Cited by 60
Drug discovery for remyelination and treatment of MS
Cole, K. L. H., Early, J. J., & Lyons, D. A. (2017) · Glia · doi:10.1002/glia.23166 · Cited by 50
Critical Review of Synthesis, Toxicology and Detection of Acyclovir
Wei, Y., Yao, L., Wu, Y., Liu, X., Peng, L., Tian, Y., Ding, J., Li, K.-H., & He, Q. (2021) · Molecules · doi:10.3390/molecules26216566 · Cited by 53
“Lee and Sung’s [116] recent research aimed at investigating drug toxicology and effects by reconstructing physiological microenvironments in vitro.”
BackgroundBridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines
Balasubramanian, V., Liu, Z., Hirvonen, J. J., & Santos, H. A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700432 · Cited by 53
Cell Microarray Technologies for High-Throughput Cell-Based Biosensors
Hong, H. J., Koom, W. S., & Koh, W. (2017) · Sensors · doi:10.3390/s17061293 · Cited by 48
Pharmacokinetic and pharmacodynamic insights from microfluidic intestine-on-a-chip models
Lee, S. H., Choi, N., & Sung, J. H. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1700950 · Cited by 45
“The figure includes images previously presented in [4] were reproduced with the permission of Wiley.”
BackgroundMethodSelf-citationLiving Cell Microarrays: An Overview of Concepts
Jonczyk, R., Kurth, T., Lavrentieva, A. V., Walter, J., Scheper, T. H., & Stahl, F. (2016) · Microarrays · doi:10.3390/microarrays5020011 · Cited by 54
A critical assessment of in vitro tissue models for ADME and drug delivery
Vellonen, K., Malinen, M. M., Mannermaa, E., Subrizi, A., Toropainen, E., Lou, Y., Kidron, H., Yliperttula, M. L., & Urtti, A. O. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.044 · Cited by 54
“man-on-chip concept) [270–272].”
BackgroundMicrotechnology-Based Multi-Organ Models
Lee, S., & Sung, J. (2017) · Bioengineering · doi:10.3390/bioengineering4020046 · Cited by 42
“The modeling processes require information on the PK profile and large quantities of PD data [4].”
BackgroundMethodInfluentialSelf-citationLee, S. H., & Jun, B. (2018) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2018.11.041 · Cited by 46
Luo, Y., Chen, Z., Hsieh, N., & Lin, T. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128658 · Cited by 45
Three-tissue microphysiological system for studying inflammatory responses in gut-liver Axis
Jeon, J., Choi, N., Lee, S. H., & Sung, J. H. (2020) · Biomedical Microdevices · doi:10.1007/s10544-020-00519-y · Cited by 41
“Many studies have focused on the development of multi-MPSs that reproduces first-pass metabolism that is related to the absorption and metabolism through interactions between the gut and liver (Choe et al. 2017; Lee et al. 2017a; Lee and Sung 2013; Lee et al. 2016; Lee and Sung 2018a).”
BackgroundSelf-citationPredicting the fluid behavior of random microfluidic mixers using convolutional neural networks
Wang, J., Zhang, N., Chen, J., Su, G., Yao, H., Ho, T.-Y., & Sun, L. (2020) · Lab on a Chip · doi:10.1039/d0lc01158d · Cited by 42
An on-chip intestine-liver model for multiple drugs absorption and metabolism behavior simulation
Jie, M., Lin, H., He, Z., Liu, H., Li, H., & Lin, J. (2017) · Science China Chemistry · doi:10.1007/s11426-017-9167-0 · Cited by 34
Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives
Çeçen, B., Karavasili, C., Nazir, M., Bhusal, A., Dogan, E., Shahriyari, F., Tamburacı, S., Büyüköz, M., Kozacı, L. D., & Miri, A. K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101657 · Cited by 42
Sheng, Q., Liu, B., Wang, X. D., Hua, L., Zhao, S.-C., Sun, X.-Z., Li, M., Zhang, X., Wang, J.-X., & Hu, P.-L. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04169-y · Cited by 45
“Metabolomics identifies subcellular toxicity signatures, such as mitochondrial dysfunction caused by persistent organic pollutants, by tracking perturbations in small-molecule metabolites (e.g., oxidative stress markers, energy metabolism intermediates) (Chen et al. 2024; Lee and Sung 2013).”
Moving towards individualized medicine with microfluidics technology
Song, P., Hu, R., Tng, D. J. H., & Yong, K. (2014) · RSC Advances · doi:10.1039/c3ra45629c · Cited by 35
Alterations in Cellular Processes Involving Vesicular Trafficking and Implications in Drug Delivery
Muro, S. (2018) · Biomimetics · doi:10.3390/biomimetics3030019 · Cited by 34
“Their fabrication derives from microelectromechanical systems and microfluidics, which enable the use of very small volumes for testing, are compatible with the length-scale of cellular systems and can better mimic the biological microenvironment [24].”
BackgroundLiver microsystems in vitro for drug response
Lee, J.-H., Ho, K.-L., & Fan, S.-K. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0575-0 · Cited by 33
Self-citationLab-on-a-chip technology and microfluidics
Francesko, A., Cardoso, V. F., & Lanceros-Méndez, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812659-2.00001-6 · Cited by 43
Arayanarakool, R., Meyer, A. K., Helbig, L., Sánchez, S., & Schmidt, O. G. (2015) · Lab on a Chip · doi:10.1039/c5lc00024f · Cited by 33
On chip two-photon metabolic imaging for drug toxicity testing
Yu, F., Zhuo, S., Qu, Y., Choudhury, D., Wang, Z., Iliescu, C., & Yu, H. (2017) · Biomicrofluidics · doi:10.1063/1.4983615 · Cited by 32
Three-Dimensional Cell Cultures in Drug Discovery and Development
Ye, F., & Eglen, R. M. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217696795 · Cited by 57
Pagnotta, G., Kalia, S., Lisa, L. D., Cicero, A. F. G., Borghi, C., & Focarete, M. L. (2022) · Bioprinting · doi:10.1016/j.bprint.2022.e00218 · Cited by 34
Advances in Microfluidics‐Based Technologies for Single Cell Culture
Alonso, D. G., Yu, M., Qu, H., Ma, L., & Shen, F. (2019) · Advanced Biosystems · doi:10.1002/adbi.201900003 · Cited by 30
de Dios-Figueroa, G. T., Aguilera-Márquez, J. D. R., Camacho-Villegas, T. A., & Lugo-Fabres, P. H. (2021) · Biomedicines · doi:10.3390/biomedicines9060602 · Cited by 35
“These bodies-on-chips can account for multiorgan interaction in drug pharmacokinetics studies and toxicity tests [83].”
BackgroundCircadian hormone control in a human-on-a-chip: In vitro biology’s ignored component?
Cyr, K. J., Avaldi, O. M., & Wikswo, J. P. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217732766 · Cited by 30
Advances in tumor microenvironment: Applications and challenges of 3D bioprinting
Dong, Y., Zhou, X., Ding, Y., Luo, Y., & Zhao, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150339 · Cited by 29
Engineering human ventricular heart tissue based on macroporous iron oxide scaffolds
Yang, H., Wei, L., Liu, C., Zhong, W., Li, B., Chen, Y., Han, R., Zhuang, J., Qu, J., Tao, H., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.02.024 · Cited by 27
Application of the Neurosphere Assay for DNT Hazard Assessment: Challenges and Limitations
Baumann, J., Dach, K., Barenys, M., Giersiefer, S., Goniwiecha, J., Lein, P. J., & Fritsche, E. (2015) · Methods in pharmacology and toxicology · doi:10.1007/7653_2015_49 · Cited by 27
Microtechnology‐based organ systems and whole‐body models for drug screening
Lee, S. H., Ha, S. K., Choi, I., Choi, N., Park, T. H., & Sung, J. H. (2016) · Biotechnology Journal · doi:10.1002/biot.201500551 · Cited by 25
“Since failure of drug development in later phases can result in a large loss on investment, accurate evaluations of drugs are essential in early phases of drug development [4, 7].”
BackgroundInfluentialSelf-citationHydrophobic Patterning‐Based 3D Microfluidic Cell Culture Assay
Han, S., Kim, J.-H., Li, R., Ma, A. L., Kwan, V. W.-S., Luong, K., & Sohn, L. L. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800122 · Cited by 26
Chen, K., Li, Y., Wang, B., Yan, X., Tao, Y., Song, W., Xi, Z., He, K., & Xia, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1101324 · Cited by 25
“The OOC models can also integrate multiple tissue compartments to mimic the function of multiple organs, allowing systematic simulation of drug metabolism in the human body and proposing more accurate prediction of drug response and toxicity, which optimizes clinical decision makings (126).”
BackgroundTechnological advances for analyzing the content of organ-on-a-chip by mass spectrometry
Hadavi, D., Tosheva, I., Siegel, T. P., Cuypers, E., & Honing, M. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1197760 · Cited by 23
“Thus far many OOCs have been developed, including specific conditions for the organ or tissue of interest.”
BackgroundInfluentialHepatocyte cultures: From collagen gel sandwiches to microfluidic devices with integrated biosensors
de Hoyos‐Vega, J. M., Hong, H. J., Stybayeva, G., & Revzin, A. (2021) · APL Bioengineering · doi:10.1063/5.0058798 · Cited by 22
Microphysiological systems: analysis of the current status, challenges and commercial future
Ribas, J., Pawlikowska, J., & Rouwkema, J. (2018) · Microphysiological Systems · doi:10.21037/mps.2018.10.01 · Cited by 23
In silico modeling of endocrine organ-on-a-chip systems
Sung, B. (2022) · Mathematical Biosciences · doi:10.1016/j.mbs.2022.108900 · Cited by 21
Lee, J., Choi, J., Ha, S. K., Choi, I., Lee, S. H., Kim, D., Choi, N., & Sung, J. H. (2014) · Lab on a Chip · doi:10.1039/c4lc00332b · Cited by 18
Self-citationHajba, L., & Guttman, A. (2017) · Journal of Flow Chemistry · doi:10.1556/1846.2017.00014 · Cited by 16
The Art of Building Living Tissues: Exploring the Frontiers of Biofabrication with 3D Bioprinting
Verma, S., Khanna, V., Kumar, S., & Kumar, S. (2023) · ACS Omega · doi:10.1021/acsomega.3c02600 · Cited by 14
Emerging microfluidics for the modeling and treatment of arthritis
Yang, N., Sun, C., Dong, C., Huang, Y., Zhu, Y., & Gu, Z. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.02.002 · Cited by 14
A universal inverse design methodology for microfluidic mixers
Zhang, N., Sun, T., Liu, Z., Zhang, Y., Xu, Y., & Wang, J. (2024) · Biomicrofluidics · doi:10.1063/5.0185494 · Cited by 12
A Highly Programmable Magnetic Micropump
Peng, X., Peng, L., & Guo, Y. (2021) · Advanced Materials Technologies · doi:10.1002/admt.202100150 · Cited by 12
From organ to system: multiorgan-on-a-chip platforms as next-generation biomedical simulators
Chen, C., Zhou, L., Kou, N., Li, X., Mao, H., & Liu, H. (2025) · Biofabrication · doi:10.1088/1758-5090/ae0dba · Cited by 11
“PDs is the study of the action of drugs on the body, i.e., the kinetic process by which drug effects vary with time and concentration [9, 150].”
Exploring the Design Efficiency of Random Microfluidic Mixers
Zhang, N., Zha, K., & Wang, J. (2021) · IEEE Access · doi:10.1109/access.2021.3050161 · Cited by 8
“ysis [2], [9], organ-on-a-chip for drug discovery [10]–[12] and toxicity studies [13], [14].”
BackgroundA cell culture system to model pharmacokinetics using adjustable-volume perfused mixing chambers
Erickson, P., Jetley, G., Amin, P., Mejevdiwala, A., Patel, A., Cheng, K.-C., & Parekkadan, B. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105623 · Cited by 7
Lab-on-a-chip techniques for high-throughput proteomics and drug discovery
Khalid, N., Arif, S., Kobayashi, I., & Nakajima, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812659-2.00014-4 · Cited by 6
Bioanalysis within Microfluidics: A Review
Jing, W., & Sui, G. (2015) · ACS symposium series · doi:10.1021/bk-2015-1215.ch013 · Cited by 7
Bonaccorsi, S. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837673476-00461 · Cited by 10
Manufacturing of Biomaterials via a 3D Printing Platform
Thayer, P., Martinez, H., & Gatenholm, E. (2018) · Wiley eBooks · doi:10.1002/9783527813704.ch4 · Cited by 6
Alternative Testing Models For Testing Chemical Toxicity
Bressler, J. P., Maertens, A., & Locke, P. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99182-7 · Cited by 4
Elnour, A. A. M., Ashammakhi, N. A., & Sallam, E. B. (2025) · Springer eBooks · doi:10.1007/978-981-97-8518-6_7 · Cited by 3
Editorial: Biotechnology Journal in Asia – the first official AFOB special issue
Park, T. H., & Chen, G. (2013) · Biotechnology Journal · doi:10.1002/biot.201300415 · Cited by 3
“Replicating the unique in vivo tissue environment has allowed reproduction of human responses to drugs, and the development of more physiologically realistic disease models [3].”
BackgroundInfluentialDelafosse, M., Regnault, E., Gebauer‐Barrett, J., Manz, A., & Sung, B. (2025) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70061 · Cited by 2
Liu, A., Xiao, K., & Lin, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1723501 · Cited by 3
“Microfluidic technology, by manipulating fluids at the microscale, can simulate the in vivo microenvironment, oering new avenues for drug screening and disease modeling (55).”
Shahabipour, F., Aldhaher, A., Doseff, A. I., Alavian, S. E., Elnour, A. A. M., & Ashammakhi, N. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99125-4.00013-5 · Cited by 2
The Promise and Challenge of Digital Biology
Samudrala, R. (2013) · Journal of Bioengineering and Biomedical Sciences · doi:10.4172/2155-9538.1000e118 · Cited by 2
Manmana, Y., Hiraoka, N., Naito, T., Kubo, T., & Otsuka, K. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00685e · Cited by 2
Microfluidic Biotechnology for “Bone‐on‐a‐Chip”
Cha, C. (2022) · Wiley eBooks · doi:10.1002/9783527831371.ch7 · Cited by 2
Fluidic Device for Generating Pharmacokinetic Profiles Matching Preset Parameters
LaPorte, B., & Musteata, F. M. (2015) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-015-9220-y · Cited by 1
“Despite recent developments in artificial organ systems, one of the main challenges of these miniaturized devices continues to consist of correctly matching the ratios of volume, mass, and flow rate between different organs on the chips [11, 17].”
BackgroundMicrofluidic Cell Culture Systems for Drug Research
Jie, M., & Lin, J. (2017) · Integrated analytical systems · doi:10.1007/978-981-10-5394-8_11 · Cited by 3
Metabolic Characterization of Cell Systems Used in In Vitro Toxicology Testing
Garcia‐Canton, C., & Minet, E. (2016) · Wiley eBooks · doi:10.1002/9780470921920.edm142 · Cited by 2
Editorial: Biotechnology Journal brings more than biotechnology
Jungbauer, A., & Lee, S. Y. (2015) · Biotechnology Journal · doi:10.1002/biot.201500581
“3D cell culture, the organon-a-chip [5, 6], and microfluidics applications [2] are such ways to reduce animal experiments, speed up the discovery process, and provide insights into disease mechanism.”
BackgroundComputational Modeling of 3D Printed Hepatic Spheroids Inside a Bioreactor
Sharifi, F., Firoozabadi, B., & Firoozbakhsh, K. K. (2018) · National and International Iranian Conference on Biomedical Engineering (ICBME) · doi:10.1109/icbme.2018.8703541
Ethical barriers to intervention development
Lai, W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816485-3.00016-7
Strategies for molecular structure elucidation in static and dynamic systems
Hadavi, D. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230530dh
Goel, M., Gupta, K., Srivastava, I., & Gabrani, R. (2025) · Advances in Science, Technology & Innovation/Advances in science, technology & innovation · doi:10.1007/978-3-031-80189-1_15
Choi, S., Lee, K. C., Park, J., & Kim, C.-U. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108534
A modular microfluidic chip unit for multiple-organ-on-chip platform integration and drug screening
Hao, Y.-J., Chen, J.-W., Ke, Y.-W., Zhao, R.-Y., Peng, H.-C., Chu, C.-Y., Yao, B.-Y., Hsiao, W., Hung, M., & Tseng, F. (2026) · The Analyst · doi:10.1039/d6an00510a
Mosina, Kumari, S., Sharma, P., Hasan, M. R., Suleman, S., Malhotra, N., & Narang, J. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00636-9
Metadata
- Authors
- Lee, J. B., & Sung, J. H.
- Affiliations
- University of Seoul (KR)
- Hongik University (KR)
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2013-08-23
- Volume
- 8
- Issue
- 11
- Pages
- 1258-1266
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2015699419
- Cited by
- 92
- References
- 68
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 9 · 2018: 11 · 2017: 16 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 2
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- organ-on-a-chip, in vitro toxicology
- MeSH terms
- Cells, Cultured, Drug Evaluation, Preclinical, Humans, Models, Biological, Pharmacokinetics, Microfluidics, Cellular Microenvironment, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.